A new paper published by Laura Louise Scott and Timothy Grant Downing of the Nelson Mandela University in South Africa, presents results about the selective toxicity of BMAA during neurogenesis in the rodent brain. The authors have observed neuropathological symptoms typically associated with Alzheimer’s Disease, Parkinson’s Disease and Amyotrophic Lateral Sclerosis following a single BMAA neonatal exposure. It is suggested that BMAA elicits its effect by altering dopamine and/or serotonin signaling in rats.
Source: Scott, L.L. and Downing, T.G. (2018), A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases. Toxins 10(1), 22. http://dx.doi.org/10.3390/toxins10010022
